Science
Mechanism of Action
Utilizes a biorenovation process where probiotic bacteria convert taro-derived polysaccharides and polyphenols into small-molecule metabolites. These actives suppress the TLR4 signaling pathway, effectively inhibiting the activation of NF-κB and MAPKs, which prevents the cascade of pro-inflammatory cytokines and enzymes like COX-2.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Demonstrated dose-dependent inhibition of pro-inflammatory markers (NO, PGE2, IL-6, IL-1β) in stimulated macrophage models (Park et al., 2021).
- 02 Patent data confirms superior reduction in iNOS and COX-2 expression compared to standard, non-fermented taro extracts at concentrations up to 5%.
Transparency
Dusting Analysis
Due to its complex INCI name and ferment status, it is frequently included at 'label claim' levels (<0.1%). Clinical efficacy for significant anti-inflammatory benefits typically requires 1.0% to 5.0%.
The Formula
Formulation
Stability
Thermally sensitive; must be incorporated during the cool-down phase at temperatures below 40°C to maintain the integrity of the ferment metabolites.
Synergies
- Ceramides
- Panthenol
- Hyaluronic Acid
Conflicts
- Strong oxidizing agents
- Low pH formulas (<4.0)
- Processing temperatures exceeding 60°C
Safety
Safety Profile
Non-cytotoxic in human-derived cell lines; characterized by a very low irritation profile even in sensitive skin models.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A scientifically advanced ferment that offers superior soothing and anti-inflammatory benefits compared to traditional botanical extracts when used at active concentrations.
Related
Similar Ingredients
Finding similar ingredients…